iBio (IBIO) Capital Expenditures (2012 - 2026)

iBio (IBIO) has 15 years of Capital Expenditures data on file, last reported at $11000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures fell 21.43% year-over-year to $11000.0 in Q1 2026; TTM through Mar 2026 was $560000.0, a 148.89% increase from a year earlier, with the FY2025 full-year figure at $16000.0, down 92.38% from the prior year.
• Capital Expenditures for Q1 2026 stood at $11000.0, down from $516000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for IBIO reached as high as $3.4 million in Q2 2022 and fell as low as -$201000.0 in Q1 2023.
• Historically, Capital Expenditures has averaged $815153.8 across 5 years, with a median of $210000.0 in 2024.
• Across the five-year window, Capital Expenditures tumbled 131.21% in 2023 and jumped 51500.0% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $3.0 million in 2022, then plunged by 82.87% to $506000.0 in 2023, then sank by 99.8% to $1000.0 in 2024, then soared by 51500.0% to $516000.0 in 2025, then slumped by 97.87% to $11000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $11000.0 in Q1 2026, $516000.0 in Q4 2025, and $32000.0 in Q3 2025.